Prevalence of Clostridium difficile Infection in the Hematopoietic Transplantation Setting: Update of Systematic Review and Meta-Analysis

Y Luo, S Zhang, H Shang, W Cui, Q Wang… - Frontiers in Cellular and …, 2022 - frontiersin.org
Hematopoietic stem cell transplant (HSCT) recipients are vulnerable to Clostridium difficile
infection (CDI) due to risk factors such as immunosuppression, antimicrobial use, and …

Epidemiology and Outcomes of Recurrent C Difficile Infection Among Hematopoietic Cell Transplant Recipients: A Single-center, Retrospective 10-year Study

E Sanchez, EM Krantz, ZK Escobar… - Open Forum …, 2024 - academic.oup.com
Background There are limited data on the contemporary epidemiology of recurrent
Clostridioides difficile infection (CDI) among hematopoietic cell transplant (HCT) recipients …

Determination of Risk Factors for Infectious Diarrhea in Patients with Hematological Malignancy

Ş Şahinkaya, Z Ture, A Unal… - Infection & …, 2024 - pmc.ncbi.nlm.nih.gov
Background This study aimed to determine the risk factors of infectious diarrhea in patients
undergoing chemotherapy or hematopoietic stem cell transplantation for hematological …

Infectious gastroenteritis in transplant patients

LR Non, D Ince - Gastroenterology Clinics, 2021 - gastro.theclinics.com
Gastrointestinal (GI) infections occur commonly after both solid organ transplantation (SOT)
and hematopoietic stem cell transplantation (HSCT). Prevalence of diarrhea is 20% to 50 …

Predictors and Temporal Trends of Mortality in Hematopoietic Stem Cell Transplant Patients with Clostridium Difficile Colitis: A Nationwide Analysis Over A Decade

S Hamid, SH Dar, M Rajamanuri… - Journal of …, 2024 - wecmelive.com
Clostridium Difficile infection (CDI) is the leading cause of healthcare-associated infections.
Hematopoietic stem cell transplant (HSCT) recipients are highly vulnerable to the …